Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (отваря нов прозорец)

Boone JD, Kim KH, Marques M, Straughn JM.

Източник‎: Gynecol Oncol 2014;132(1):227-30.

Статията е индексирана‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (отваря нов прозорец)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (отваря нов прозорец)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Източник‎: N Engl J Med 2011;365(26):2453-62.

Статията е индексирана‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (отваря нов прозорец)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (отваря нов прозорец)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Източник‎: Transfusion 2016;56(10):2438-42.

Статията е индексирана‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (отваря нов прозорец)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (отваря нов прозорец)

Ford PA, Grant SJ, Mick R, Keck G.

Източник‎: J Clin Oncol 2015;33(15):1674-9.

Статията е индексирана‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (отваря нов прозорец)

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (отваря нов прозорец)

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

Източник‎: Transfus Med Rev 2002;16(1):34-45.

Статията е индексирана‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 (отваря нов прозорец)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (отваря нов прозорец)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Източник‎: N Engl J Med 1999;340(6):409-17.

Статията е индексирана‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (отваря нов прозорец)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (отваря нов прозорец)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Източник‎: Intensive Care Med 2013;39(3):445-53.

Статията е индексирана‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (отваря нов прозорец)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (отваря нов прозорец)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Източник‎: Cancer Treat Rev 2016;46:1-8.

Статията е индексирана‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (отваря нов прозорец)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (отваря нов прозорец)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Източник‎: Transfusion 2014;54(10 Pt 2):2678-86.

Статията е индексирана‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (отваря нов прозорец)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (отваря нов прозорец)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Източник‎: J Clin Oncol 2020;38(13):1463-73.

Статията е индексирана‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (отваря нов прозорец)

Transfusion indications for patients with cancer. (отваря нов прозорец)

Watkins T, Surowiecka MK, McCullough J.

Източник‎: Cancer Control 2015;22(1):38-46.

Статията е индексирана‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (отваря нов прозорец)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (отваря нов прозорец)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Източник‎: Am J Surg 2015;210(6):1197-204.

Статията е индексирана‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (отваря нов прозорец)